We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Transfusion Management System Assures Patient Safety

By Labmedica staff writers
Posted on 29 Jul 2008
A point-of-care (POC) transfusion safety management system assists nurses, phlebotomists, and laboratory personnel in assuring that blood samples are drawn from correct patients and administered to suitable patients. More...


The new POC transfusion safety-management system is composed of computers, a software application, wireless handheld barcode scanners, and wireless printers. In addition to helping laboratory personnel in the accurate matching of blood samples with correct blood or blood products, it enables immediate documentation of any adverse reaction data.

A product of IntelliDOT Corp. (San Diego, CA, USA), the management system is called the IntelliDOT blood product administration (IntelliDOT BPA). The company announced that the U.S. Food and Drug Administration (FDA; Rockville, MD, USA) granted 510(k) clearance for the IntelliDOT BPA for commercial sale.

"The FDA approval for IntelliDOT blood product administration advances our corporate mission to provide innovative and easy-to-adopt, point-of-care solutions to enhance patient safety, improve nurse efficiency, and help hospitals reduce risk and liability,” said Thomas G. Klopack, president and CEO of IntelliDOT. "With this latest addition, IntelliDOT extends its ability to support improved quality of care across the full spectrum of patient needs.”

IntelliDOT BPA is an integrated module of the IntelliDOT CAREt system, the manager that connects caregivers with the information systems they need at the point-of-care. The other currently available modules in the CAREt system include: IntelliDOT bedside medication administration, IntelliDOT phlebotomy specimen collection, IntelliDOT mother-baby breast milk matching, and IntelliDOT vital signs collection.

IntelliDOT is a provider of wireless, handheld, barcode point-of- care (BPOC) solutions that connect to any healthcare information system to improve patient safety and nurse workflow. When using the IntelliDOT system, nurses can easily manage all tasks associated with medication-administration safety checks and related documentation.


Related Links:
U.S. Food and Drug Administration
IntelliDOT

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.